ProQR Therapeutics/$PRQR
1D1W1MYTD1Y5YMAX
Capital at risk
About ProQR Therapeutics
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
- Ticker
- $PRQR
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 187
- Headquarters
- Leiden, Netherlands
- Website
- www.proqr.com
PRQR Metrics
BasicAdvanced
$262M
-
-$0.46
0.06
-
Price and volume
Market cap
$262M
Beta
0.06
52-week high
$3.10
52-week low
$1.33
Average daily volume
860K
Financial strength
Current ratio
3.488
Quick ratio
3.488
Long term debt to equity
0.109
Total debt to equity
0.193
Interest coverage (TTM)
-46.13%
Profitability
EBITDA (TTM)
-48.336
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-228.18%
Operating margin (TTM)
-232.60%
Effective tax rate (TTM)
-0.06%
Revenue per employee (TTM)
$115,350
Management effectiveness
Return on assets (TTM)
-19.76%
Return on equity (TTM)
-57.40%
Valuation
Price to revenue (TTM)
9.322
Price to book
2.57
Price to tangible book (TTM)
2.57
Price to free cash flow (TTM)
-3.424
Free cash flow yield (TTM)
-29.21%
Free cash flow per share (TTM)
-0.543
Growth
Revenue change (TTM)
7.49%
Earnings per share change (TTM)
-1.08%
3-year revenue growth (CAGR)
65.84%
10-year revenue growth (CAGR)
18.48%
3-year earnings per share growth (CAGR)
-17.04%
10-year earnings per share growth (CAGR)
-11.74%
What the Analysts think about PRQR
Analyst ratings (Buy, Hold, Sell) for ProQR Therapeutics stock.
Analyst projections of the future price of ProQR Therapeutics stock.
PRQR Financial Performance
Revenues and expenses
PRQR Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing PRQR
Fund name | Fund size | $PRQR weighting |
|---|---|---|
Xtrackers S&P 500 Swap£XSPX | £3.1B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.